Publications by authors named "Edward S Kim"

100Publications

Management changes for patients with endocrine-related cancers in the COVID-19 pandemic.

Endocr Relat Cancer 2020 09;27(9):R357-R374

Departments of Solid Tumor Oncology, Endocrinology, and Urologic Oncology, Levine, Cancer Institute, Charlotte, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-20-0229DOI Listing
September 2020

Response to Letter to the Editor.

J Thorac Oncol 2020 Jul 11;15(7):e110-e111. Epub 2020 Jun 11.

Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2020.05.011DOI Listing
July 2020

Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases.

J Thorac Oncol 2020 05 10;15(5):803-815. Epub 2020 Jan 10.

Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.12.126DOI Listing
May 2020

Pulmonary Carcinosarcoma: A Surveillance, Epidemiology, and End Results (SEER) Analysis.

Clin Lung Cancer 2020 03 10;21(2):160-170. Epub 2019 Jul 10.

Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2019.07.001DOI Listing
March 2020

Critical Aspects of a Sustainable Clinical Research Program in the Community-Based Oncology Practice.

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:176-184. Epub 2019 May 17.

1 Levine Cancer Institute, Atrium Health, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_238485DOI Listing
January 2019

Implementing Precision Medicine in Community-Based Oncology Programs: Three Models.

J Oncol Pract 2019 06 25;15(6):325-329. Epub 2019 Feb 25.

1 American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00661
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00661DOI Listing
June 2019

Gene Therapy in Head and Neck Cancer.

Oral Maxillofac Surg Clin North Am 2019 Feb 25;31(1):117-124. Epub 2018 Oct 25.

Head and Neck Division, Department of Solid Tumor Oncology, Levine Cancer Institute, 1021 Morehead Medical Drive, Suite 3200, Charlotte, NC 28204, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coms.2018.08.006DOI Listing
February 2019

Moving away (finally) from doublet therapy in lung cancer: immunotherapy and KEYNOTE-189.

J Thorac Dis 2018 Sep;10(9):5186-5189

Department of Solid Tumor Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/24270/18317
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.09.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196172PMC
September 2018

Implementing Precision Medicine Programs and Clinical Trials in the Community-Based Oncology Practice: Barriers and Best Practices.

Am Soc Clin Oncol Educ Book 2018 May;38:188-196

From the Levine Cancer Institute, Atrium Health, Charlotte, NC; Sanford Research, Sioux Falls, SD; Aurora Health Care, Milwaukee, WI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_200633DOI Listing
May 2018

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.

Ann Thorac Surg 2018 Feb 6;105(2):418-424. Epub 2017 Dec 6.

Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2017.08.052DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783769PMC
February 2018

Prognostic and predictive biomarkers post curative intent therapy.

Ann Transl Med 2017 Sep;5(18):374

Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2017.07.34DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635255PMC
September 2017

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement.

J Clin Oncol 2017 Nov 2;35(33):3737-3744. Epub 2017 Oct 2.

Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; Suanna S. Bruinooge, Caroline Schenkel, and Richard L. Schilsky, ASCO, Alexandria, VA; Samantha Roberts, Marina Kozak, Jeff Allen, and Ellen Sigal, Friends of Cancer Research; Samantha Roberts, Genentech, Washington, DC; Gwynn Ison, Julia A. Beaver, Rajeshwari Sridhara, and Tatiana M. Prowell, US Food and Drug Administration, Silver Spring; Thomas S. Uldrick and Andrea M. Denicoff, National Cancer Institute, Bethesda, MD; Nancy U. Lin, Dana-Farber Cancer Institute, Boston; Paul J. Hesketh, Lahey Health Cancer Institute, Burlington, MA; Lia Gore, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO; Stuart M. Lichtman, Memorial Sloan-Kettering Cancer Center, New York, NY; Nancy Roach, Fight Colorectal Cancer, Springfield, MO; Elizabeth Garrett-Mayer, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Eric Rubin, Merck Research Laboratories, Kenilworth, NJ; and Pratik Multani, Ignyta, San Diego, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.7916DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5692724PMC
November 2017

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Brain Metastases Working Group.

J Clin Oncol 2017 Nov 2;35(33):3760-3773. Epub 2017 Oct 2.

Nancy U. Lin, Dana-Farber Cancer Institute, Boston; Oliver Rosen, Deciphera Pharmaceuticals, Waltham, MA; Tatiana Prowell, Laleh Amiri-Kordestani, and Joohee Sul, US Food and Drug Administration, Silver Spring; Tatiana Prowell, Johns Hopkins Kimmel Cancer Center, Baltimore, MD; Antoinette R. Tan and Edward S. Kim, Carolinas HealthCare System, Charlotte, NC; Marina Kozak, Friends of Cancer Research; Louise Perkins, Melanoma Research Alliance, Washington, DC; Julia White, The Ohio State University, Columbus, OH; Katherine Beal, Memorial Sloan Kettering Cancer Center, New York, NY; and Richard Gaynor, Eli Lilly, Indianapolis, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.0761DOI Listing
November 2017

Gefitinib for patients with incurable cutaneous squamous cell carcinoma: A single-arm phase II clinical trial.

J Am Acad Dermatol 2017 Dec 28;77(6):1110-1113.e2. Epub 2017 Sep 28.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2017.07.048DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685879PMC
December 2017

Efficacy and Safety Results of the Afatinib Expanded Access Program.

Oncol Ther 2017 10;5(1):103-110. Epub 2017 Apr 10.

Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40487-017-0043-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488108PMC
April 2017

Systematic Review of Brain Metastases in Patients With Non-Small-Cell Lung Cancer in the United States, European Union, and Japan.

Clin Lung Cancer 2017 11 26;18(6):607-614. Epub 2017 Apr 26.

Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.04.011DOI Listing
November 2017

Clinical Pathways and the Patient Perspective in the Pursuit of Value-Based Oncology Care.

Am Soc Clin Oncol Educ Book 2017 ;37:597-606

From the Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; Baylor University Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_174794DOI Listing
November 2017

Precision Oncology: Who, How, What, When, and When Not?

Am Soc Clin Oncol Educ Book 2017 ;37:160-169

From the University of Tennessee Health Science Center, Memphis, TN; Levine Cancer Institute, Charlotte, SC; Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_174176DOI Listing
December 2017

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.

J Clin Oncol 2017 Aug 5;35(22):2490-2498. Epub 2017 May 5.

Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Sang-We Kim, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Karen L. Reckamp, City of Hope, Duarte, CA; Karin Holmskov Hansen, Odense University Hospital, Odense, Denmark; Rudolf M. Huber, University Hospital of Munich, German Centre for Lung Research, Munich, Germany; Howard L. West, Swedish Cancer Institute, Seattle, WA; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Maximilian J. Hochmair, Otto Wagner Hospital, Vienna, Austria; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Scott N. Gettinger, Yale Cancer Center, New Haven, CT; Corey J. Langer, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Luis G. Paz-Ares Rodríguez, Hospital Universitario 12 de Octubre, Madrid, Spain; Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; William Reichmann, Frank G. Haluska, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; and D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.5904DOI Listing
August 2017

The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long-term community-based cancer center experience.

Cancer Med 2017 03 11;6(3):516-525. Epub 2017 Feb 11.

Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.972DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345681PMC
March 2017

Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual.

Clin Cancer Res 2016 Nov 6;22(22):5397-5399. Epub 2016 Sep 6.

Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1710DOI Listing
November 2016

Mutational Markers and Risk Stratification in Thyroid Cancer-The Art of War Refined.

JAMA Oncol 2017 Feb;3(2):209-210

Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.3286DOI Listing
February 2017

Transforming Clinical Trial Eligibility Criteria to Reflect Practical Clinical Application.

Am Soc Clin Oncol Educ Book 2016 ;35:83-90

From the Department of Medicine, Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_155880DOI Listing
January 2017

Lung cancer biomarkers, targeted therapies and clinical assays.

Transl Lung Cancer Res 2015 Oct;4(5):503-14

Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2218-6751.2015.06.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630522PMC
October 2015

New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.

Cancer Prev Res (Phila) 2015 Nov 4;8(11):1027-35. Epub 2015 Sep 4.

Cancer Research Center of Lyon, UMR INSERM 1052-CNRS 5286, Lyon, France. Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France. Department of Medicine, Centre Léon Bérard, Lyon, France. Université de Lyon, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-14-0179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777304PMC
November 2015

Modernizing Eligibility Criteria for Molecularly Driven Trials.

J Clin Oncol 2015 Sep 20;33(25):2815-20. Epub 2015 Jul 20.

Edward S. Kim, Jennifer L. Ersek, and Earle Burgess, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; David Bernstein, Suanna S. Bruinooge, and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Susan G. Hilsenbeck, Dan L. Duncan Cancer Center, Baylor College of Medicine; Kelly Hunt, University of Texas MD Anderson Cancer Center, Houston, TX; Christine H. Chung, Johns Hopkins University School of Medicine, Baltimore; Percy Ivy, National Cancer Institute, Bethesda, MD; Adam P. Dicker, Sidney Kimmel Medical College and Cancer Center at Thomas Jefferson University, Philadelphia, PA; Steven Stein, Novartis, East Hanover, NJ; Fadlo R. Khuri, Winship Cancer Institute, Emory University, Atlanta, GA; and Neal Meropol, University Hospitals Case Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.1854DOI Listing
September 2015

The Future of Molecular Medicine: Biomarkers, BATTLEs, and Big Data.

Authors:
Edward S Kim

Am Soc Clin Oncol Educ Book 2015 :22-7

From the Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.22DOI Listing
February 2016

Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer.

Oncotarget 2015 Jun;6(18):16746-56

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599304PMC
http://dx.doi.org/10.18632/oncotarget.3796DOI Listing
June 2015

Improving the Care of Patients With Stage IB Non-Small-Cell Lung Cancer: Role of Prognostic Signatures and Use of Cell Cycle Progression Biomarkers.

Clin Lung Cancer 2015 Jul 6;16(4):245-51. Epub 2015 Mar 6.

Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2015.02.008DOI Listing
July 2015

Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.

J Thorac Oncol 2015 Apr;10(4):682-90

*Department of Thoracic/Head & Neck Medical Oncology, †Department of Genomic Medicine, ‡Department of Biostatistics, §Department of Thoracic and Cardiovascular Surgery, MD Anderson Cancer Center, The University of Texas, Houston TX; ‖Department of Medicine, Harvard Medical School, Mount Auburn Hospital, Cambridge, MA; and ¶Levine Cancer Institute, Carolina HealthCare System, Charlotte, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000456DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368494PMC
April 2015

Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.

Clin Lung Cancer 2014 May 1;15(3):213-21. Epub 2014 Jan 1.

Department of Thoracic/Head & Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX; College of Pharmacy, Seoul National University, Seoul, South Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304130026
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2013.12.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572464PMC
May 2014

Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy.

Clin Cancer Res 2014 Apr 23;20(7):1946-54. Epub 2013 Dec 23.

Authors' Affiliations: Departments of Thoracic/Head and Neck Medical Oncology, Biostatistics, Pathology, and Thoracic and Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; Levine Cancer Center; Philips Digital Pathology; and Department of Pathology, University of San Francisco Xavier de Chuquisaca Sucre-Bolivia, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1959DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018222PMC
April 2014

Identification of a subset of human non-small cell lung cancer patients with high PI3Kβ and low PTEN expression, more prevalent in squamous cell carcinoma.

Clin Cancer Res 2014 Feb 27;20(3):595-603. Epub 2013 Nov 27.

Authors' Affiliations: AstraZeneca R&D; Former AstraZeneca, Macclesfield, Cheshire, United Kingdom; Departments of Translational Molecular Pathology and Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; AstraZeneca, Asia and Emerging Markets iMed, Shanghai, China; Novartis Institutes for BioMedical Research, Basel, Switzerland; and Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1638DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503252PMC
February 2014

Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer: SWOG S0536.

J Thorac Oncol 2013 Dec;8(12):1519-28

*Levine Cancer Institute, Charlotte, North Carolina; †SWOG Statistical Center, Seattle, Washington; ‡Yale Cancer Center, New Haven, Connecticut; §Cancer Center of Kansas and Wichita CCOP, Wichita, Kansas; ‖Central Illinois CCOP and Cancer Care Specialists, Decatur, Illinois; ¶University of Colorado Cancer Center, Aurora, Colorado; #University of California Davis Cancer Center, Sacramento, California; and **MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072123PMC
December 2013

Comprehensive biomarker analysis and final efficacy results of sorafenib in the BATTLE trial.

Clin Cancer Res 2013 Dec 28;19(24):6967-75. Epub 2013 Oct 28.

Authors' Affiliations: Departments of Thoracic/Head and Neck Medical Oncology, Biostatistics and Applied Mathematics, Translational Molecular Pathology, Diagnostic Imaging, Diagnostic Radiology, and Bioinformatics and Computational Biology; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston; The Hamon Center for Therapeutic Oncology Research and Departments of Internal Medicine and Pharmacology, The University of Texas Southwestern Medical Center, Dallas, Texas; Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Charlotte, North Carolina; Medical Oncology, Yale Cancer Center, New Haven, Connecticut; Division of Medical Oncology, University of Ottawa, Ottawa, Ontario; Department of Oncology and Diagnostic Sciences, University of Maryland Dental School, Baltimore, Maryland; UC San Diego Moores Cancer Center, La Jolla, California; and Centre de Recherche en Cancérologie de Lyon, UMR INSERM 1052-CNRS 5286, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-1818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905243PMC
December 2013

Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma.

Clin Cancer Res 2013 Nov 18;19(22):6261-71. Epub 2013 Sep 18.

Authors' Affiliations: Departments of Translational Molecular Pathology, Thoracic/Head and Neck, Pathology, and Thoracic and Cardiovascular Surgery, The University of Texas, MD Anderson Cancer Center, Houston, Texas; Myriad Genetics, Inc., Salt Lake City, Utah; and Istituto Europeo di Oncologia, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0596DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834029PMC
November 2013

Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial.

J Thorac Oncol 2013 Apr;8(4):436-42

Department of Diagnostic Radiology, Unit 1471, The University of Texas, M.D. Anderson Cancer Center, PO Box 301402, Houston, TX 77230, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318287c91eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879952PMC
April 2013

Epidermal growth factor receptor inhibition in lung cancer: status 2012.

J Thorac Oncol 2013 Mar;8(3):373-84

Department of Medicine, Division of Medical Oncology and Department of Pathology, University of Colorado Cancer Center, 12801 E. 17th Avenue, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31827ed0ffDOI Listing
March 2013

Personalizing lung cancer prevention through a reverse migration strategy.

Top Curr Chem 2013 ;329:221-40

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/128_2012_338DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737590PMC
March 2013

Vandetanib for the treatment of lung cancer.

Expert Opin Investig Drugs 2012 Aug 6;21(8):1211-21. Epub 2012 Jun 6.

The University of Texas MD Anderson Cancer Center, Department of Thoracic/Head and Neck Medical Oncology, 1515 Holcombe Boulevard, Box 432, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2012.694866DOI Listing
August 2012

New strategies in squamous cell carcinoma of the lung: identification of tumor drivers to personalize therapy.

Clin Cancer Res 2012 Jun 29;18(11):3002-7. Epub 2012 Mar 29.

Departments of Thoracic/Head and Neck Medical Oncology and Pathology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3737591PMC
June 2012

Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells.

Biochem Pharmacol 2012 May 22;83(10):1456-64. Epub 2012 Feb 22.

Department of Thoracic and Cardiovascular Surgery, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2012.02.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391570PMC
May 2012

A multiplicity of anti-invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer.

Int J Cancer 2012 Aug 31;131(3):537-47. Epub 2012 Jan 31.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.26373DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3374925PMC
August 2012

Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer.

Cancer 2012 May 22;118(9):2454-65. Epub 2011 Sep 22.

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.26492
Publisher Site
http://dx.doi.org/10.1002/cncr.26492DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298843PMC
May 2012

The BATTLE to personalize lung cancer prevention through reverse migration.

Cancer Prev Res (Phila) 2011 Jul;4(7):962-72

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/lookup/doi/
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171137PMC
July 2011

Cotargeting cyclin D1 starts a new chapter in lung cancer prevention and therapy.

Cancer Prev Res (Phila) 2011 Jun;4(6):779-82

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/cgi/doi/10.
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-11-0143DOI Listing
June 2011

Computed tomography findings predicting invasiveness of thymoma.

J Thorac Oncol 2011 Jul;6(7):1274-81

Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31821c4203DOI Listing
July 2011

Air travel after biopsy-related pneumothorax: is it safe to fly?

J Vasc Interv Radiol 2011 May;22(5):595-602.e1

Department of Diagnostic Radiology, Section of Interventional Radiology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jvir.2011.01.436DOI Listing
May 2011

Prevention of bronchial hyperplasia by EGFR pathway inhibitors in an organotypic culture model.

Cancer Prev Res (Phila) 2011 Aug 19;4(8):1306-15. Epub 2011 Apr 19.

Department of Thoracic/Head and Neck Medical Oncology, Unit 432, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-10-0364DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151315PMC
August 2011

Gene expression profiling predicts the development of oral cancer.

Cancer Prev Res (Phila) 2011 Feb;4(2):218-29

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-10-0155DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074595PMC
February 2011

Bronchioloalveolar carcinoma: a translational perspective.

Oncology (Williston Park) 2010 Sep;24(10):907-8, 914

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
September 2010

The multidisciplinary approach to thymoma: combining molecular and clinical approaches.

J Thorac Oncol 2010 Oct;5(10 Suppl 4):S313-7

Division of Medical Oncology and Hematology, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181f20d9aDOI Listing
October 2010

Bevacizumab: current updates in treatment.

Curr Opin Oncol 2010 Nov;22(6):586-91

Department of Thoracic/Head and Neck Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00001622-201011000-000
Publisher Site
http://dx.doi.org/10.1097/CCO.0b013e32833edc0cDOI Listing
November 2010

Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer.

Cancer 2010 May;116(10):2401-8

Department of Thoracic/Head & Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24996DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145307PMC
May 2010

Biological activity of celecoxib in the bronchial epithelium of current and former smokers.

Cancer Prev Res (Phila) 2010 Feb 26;3(2):148-59. Epub 2010 Jan 26.

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-09-0233DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028718PMC
February 2010